S. 4525

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 4525 Introduced in Senate (IS)]

<DOC>

119th CONGRESS
2d Session
S. 4525

To prohibit certain federally funded research collaborations with 
certain foreign entities, and for other purposes.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

May 14, 2026

Mr. Banks introduced the following bill; which was read twice and 
referred to the Committee on Homeland Security and Governmental Affairs

_______________________________________________________________________

A BILL

To prohibit certain federally funded research collaborations with 
certain foreign entities, and for other purposes.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Securing Innovation and Research 
from Adversaries Act''.

SEC. 2. PROHIBITION ON FEDERALLY FUNDED RESEARCH RELATIONSHIPS WITH 
CERTAIN FOREIGN ENTITIES.

(a) Prohibition.--No Federal funds awarded through a federally 
funded research award may be used by an individual or entity described 
in subsection (b) to enter into, support, or carry out any research 
collaboration with--
(1) an entity listed on a United States Government 
restricted entity list; or
(2) an individual associated with such an entity.
(b) Individual or Entity Described.--An individual or entity 
described in this subsection is an individual or entity participating 
in, receiving, or performing work under a federally funded research 
award.
(c) Guidance.--To carry out this section, the Director of the 
Office of Science and Technology Policy, in consultation with the heads 
of relevant Federal research agencies, shall issue Government-wide 
implementation guidance to ensure standardized compliance requirements, 
definitions, and enforcement mechanisms.
(d) Waiver Authority.--
(1) In general.--The head of a Federal agency may waive the 
prohibition under subsection (a), on a case-by-case basis, if 
such head determines--
(A) the waiver is necessary to advance the national 
security interests of the United States; or
(B) the research collaboration under subsection (a) 
that is the subject of the waiver is essential for a 
clearly defined scientific, public health, or national 
security purpose that cannot reasonably be achieved 
without such collaboration.
(2) Report.--Not later than 30 days after granting a waiver 
under paragraph (1), the head of the Federal agency who granted 
the waiver shall submit to Congress a written notification that 
includes the following:
(A) The identity of the individual or entity that 
is the subject of waiver.
(B) The justification for such waiver.
(C) The mitigation measures implemented to protect 
the national security interests of the United States, 
if applicable.
(e) Definitions.--In this section:
(1) Federally funded research award.--The term ``federally 
funded research award'' means a grant, contract, cooperative 
agreement, other Federal financial assistance (as defined in 
section 200.1 of title 2, Code of Federal Regulations), or 
other award issued under other transaction authority.
(2) National laboratory.--The term ``National Laboratory'' 
has the meaning given such term in section 2 of the Energy 
Policy Act of 2005 (42 U.S.C. 15801).
(3) Research collaboration.--The term ``research 
collaboration'' means any activity conducted as part of a 
federally funded research award, including the following:
(A) Joint research activities or projects.
(B) Co-authorship of scholarly publications, 
technical reports, or research outputs.
(C) Data or processing sharing, material transfer, 
or exchange of research results, including access to 
datasets, software, or research infrastructure.
(D) Joint laboratories, research centers, or 
institutes.
(E) Personnel exchanges, visiting scholar 
appointments, or joint supervision of students or 
researchers.
(F) Any other arrangement determined by the head of 
the relevant Federal research funding agency to 
constitute research collaboration.
(4) United states government restricted entity lists.--The 
term ``United States Government restricted entity list'' 
includes the following:
(A) Any of the following lists maintained by the 
Bureau of Industry and Security of the Department of 
Commerce:
(i) The Entity List set forth in Supplement 
No. 4 to part 744 of title 15, Code of Federal 
Regulations.
(ii) The Unverified List set forth in 
Supplement No. 6 to part 744 of that title.
(iii) The Military End-User List set forth 
in Supplement No. 7 to part 744 of that title.
(iv) The Denied Persons List maintained 
pursuant to section 764.3(a)(2) of that title.
(B) The list of specially designated nationals and 
blocked persons maintained by the Office of Foreign 
Assets Control of the Department of the Treasury 
(commonly referred to as the ``SDN list'').
(C) The list of Chinese military companies 
operating in the United States required by section 
1260H of the William M. (Mac) Thornberry National 
Defense Authorization Act for Fiscal Year 2021 (Public 
Law 116-283; 10 U.S.C. 113 note).
(D) The lists of debarred parties maintained by the 
Directorate of Defense Trade Controls of the Department 
of State pursuant to section 38(g)(4) of the Arms 
Export Control Act (22 U.S.C. 2778(g)(4)).
(E) The list of telecommunications companies of the 
People's Republic of China described in section 
889(f)(3) of the John S. McCain National Defense 
Authorization Act for Fiscal Year 2019 (Public Law 115-
232; 41 U.S.C. 3901 note prec.).
(F) The list of academic institutions of the 
People's Republic of China maintained under section 
1286(c)(9)(A) of the John S. McCain National Defense 
Authorization Act for Fiscal Year 2019 (Public Law 115-
232; 10 U.S.C. 4001 note).
(G) The list of semiconductor companies of the 
People's Republic of China described in section 
5949(j)(3) of the James M. Inhofe National Defense 
Authorization Act for Fiscal Year 2023 (Public Law 117-
263; 41 U.S.C. 4713 note).
(H) The list of biotechnology companies of concern 
maintained under section 851(f) of the National Defense 
Authorization Act for Fiscal Year 2026 (Public Law 119-
60; 41 U.S.C. 3901 note prec.).
(I) The list of entities that produce or provide 
communications equipment or service on the list 
published by the Federal Communications Commission 
under section 2(a) of the Secure and Trusted 
Communications Networks Act of 2019 (47 U.S.C. 
1601(a)).
(J) A list maintained under clause (i), (ii), (iv), 
or (v) of section 2(d)(2)(B) of the Act entitled ``An 
Act to ensure that goods made with forced labor in the 
Xinjiang Autonomous Region of the People's Republic of 
China do not enter the United States market, and for 
other purposes'', approved December 23, 2021 (Public 
Law 117-78; 22 U.S.C. 6901 note), (commonly referred to 
as the ``Uyghur Forced Labor Prevention Act'').
(K) The Annex to Executive Order 14032 (50 U.S.C. 
1701 note; relating to addressing the threat from 
securities investments that finance certain companies 
of the People's Republic of China), or a successor 
order.
(L) Any other list of entities designated by the 
President, the Secretary of Commerce, the Secretary of 
the Treasury, or the Secretary of Defense and with 
which transactions are restricted or prohibited for 
national security, foreign policy, or human rights 
reasons.
<all>